Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyqvia in multifocal motor neuropathy
NL-OMON44726Active, not recruiting
- Sponsor
- Nederlandse Federatie van Universitair Medische Centra
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Human normal immunoglobulin G in multifocal motor neuropathy (MMN), sponsored by Nederlandse Federatie van Universitair Medische Centra. Primary endpoints: Safety/tolerability of Hyqvia compared to IVIg and Clinical effect of Hyqvia compared to IVIg. Started Nov 2016; status: active, not recruiting.
02
Drugs
Human normal immunoglobulin G
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NL-OMON44726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44726.